Antimalarial drug regimens prescribed n (%) Non-artemisinin monotherapies (
NAMTs) 8 (2.4) Proguanil 5 (1.5) Sulphadoxine-Pyrimethamine 2 (0.6) Amodiaquine 1 (0.3) Artemisinin monotherapies (AMTs) 6 (1.8) Artesunate 2 (0.6) Arteether 2 (0.6) Artemether 1 (0.3) Dihydroartemisinin 1 (0.3) Artemisinin combination therapies (ACTs) 319 (95.8) Artemether/Lumefantrine 269 (80.8) Artesunate/ Meflo quine 20 (6.0) Dihydroartemisinin/Piperaquine 16 (4.8) Artesunate/Amo diaquine 8 (2.4) Artesunate/Piperaquine 4(1.2) Artemether/Lumefantrine + Sulphadoxine-Pyrimethamine 1 (0.3) Artesunate/Sulphadoxine-Pyrimethamine + Proguanil 1 (0.3) Table 3: Drug prescribing indicators.
AMPS Advanced Mobile Phone System IMTS Improved Mobile Telephone Service IS-41 Interim Standard(*) for AMPS N-AMPS Narrowband version of AMPS
NAMTS Japanese mobile system NMT450 Nordic Mobile Telephone 450 MHz NMT900 Nordic Mobile Telephone 900 MHz TACS Total Access Communications System ETACS TACS version used in Asia JTACS TACS version used in Japan